Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
Status:
Completed
Trial end date:
2001-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients with
advanced gallbladder or bile duct cancer that cannot be removed surgically.